Press Release: Enlyte and Former Genex Leaders Reach Agreement to Create New IME Business
Read the full Press Release here.
SAN DIEGO, CA - March 5, 2024. Enlyte and its Board of Directors have made the strategic decision to transfer its Independent Medical Examination (IME) business and more than 350 employees from Enlyte to the creation of a new, stand-alone IME company, Emperion, Inc. Emperion will be owned by Stone Point Capital, Enlyte’s current shareholder, through its Trident Funds and a management team led by former Genex executives.